Austin Gurney insider trades: OncoMed Pharmaceuticals (OMED) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Austin reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 24, 2018 | OMED | ↓ Sell | 11,117 | $0.60 | $7K | Direct | Dec 26, 2018 (2d) |
| Oct 10, 2018 | OMED | ↓ Sell | 1,156 | $2.01 | $2K | Direct | Oct 11, 2018 (1d) |
| Oct 9, 2018 | OMED | ↓ Sell | 1,686 | $2.13 | $4K | Direct | Oct 10, 2018 (1d) |
| Apr 24, 2018 | OMED | ↓ Sell | 4,051 | $2.68 | $11K | Direct | Apr 26, 2018 (2d) |
| Oct 10, 2017 | OMED | ↓ Sell | 1,248 | $4.24 | $5K | Direct | Oct 12, 2017 (2d) |
| Apr 4, 2017 | OMED | ↓ Sell | 5,754 | $9.06 | $52K | Direct | Apr 5, 2017 (1d) |
| Jan 7, 2016 | OMED | ↓ Sell | 2,162 | $22.28 | $48K | Direct | Jan 8, 2016 (1d) |
| Oct 26, 2015 | OMED | ↓ Sell | 14,000 | $20.00 | $280K | Direct | Oct 27, 2015 (1d) |
| Jul 30, 2015 | OMED | ↓ Sell | 14,000 | $20.88 | $292K | Direct | Jul 31, 2015 (1d) |
| May 18, 2015 | OMED | ↓ Sell | 4,000 | $22.48 | $90K | Direct | May 20, 2015 (2d) |
| Apr 17, 2015 | OMED | ↓ Sell | 4,000 | $25.51 | $102K | Direct | Apr 20, 2015 (3d) |
| Mar 17, 2015 | OMED | ↓ Sell | 4,000 | $27.37 | $109K | Direct | Mar 19, 2015 (2d) |
| Feb 17, 2015 | OMED | ↓ Sell | 4,000 | $26.37 | $105K | Direct | Feb 19, 2015 (2d) |
| Jan 20, 2015 | OMED | ↓ Sell | 4,000 | $22.87 | $91K | Direct | Jan 21, 2015 (1d) |
| Dec 17, 2014 | OMED | ↓ Sell | 4,000 | $20.00 | $80K | Direct | Dec 19, 2014 (2d) |
| Nov 17, 2014 | OMED | ↓ Sell | 4,000 | $20.16 | $81K | Direct | Nov 19, 2014 (2d) |
| Oct 17, 2014 | OMED | ↓ Sell | 4,000 | $20.07 | $80K | Direct | Oct 20, 2014 (3d) |
| Oct 2, 2014 | OMED | ↓ Sell | 4,000 | $20.00 | $80K | Direct | Oct 3, 2014 (1d) |
| Aug 22, 2014 | OMED | ↓ Sell | 4,000 | $20.00 | $80K | Direct | Aug 25, 2014 (3d) |
| Jul 17, 2014 | OMED | ↓ Sell | 4,000 | $20.46 | $82K | Direct | Jul 18, 2014 (1d) |
| Jun 17, 2014 | OMED | ↓ Sell | 4,000 | $24.99 | $100K | Direct | Jun 18, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Austin Gurney's insider trades
Austin Gurney is See Remarks at OncoMed Pharmaceuticals (OMED). Since Jun 17, 2014, Austin has reported no open-market purchases and 21 sales worth $1.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.